141 related articles for article (PubMed ID: 21232594)
21. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
22. Cholic acid-carboplatin compounds (CarboChAPt) as models for specific drug delivery: synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic properties with corresponding cisplatin compounds.
Paschke R; Kalbitz J; Paetz C; Luckner M; Mueller T; Schmoll HJ; Mueller H; Sorkau E; Sinn E
J Inorg Biochem; 2003 Apr; 94(4):335-42. PubMed ID: 12667704
[TBL] [Abstract][Full Text] [Related]
23. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
Alberts DS; Fanta PT; Running KL; Adair LP; Garcia DJ; Liu-Stevens R; Salmon SE
Cancer Chemother Pharmacol; 1997; 39(6):493-7. PubMed ID: 9118460
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
25. Iron-salophen complexes involving azole-derived ligands: A new group of compounds with high-level and broad-spectrum in vitro antitumor activity.
Vančo J; Šindelář Z; Dvořák Z; Trávníček Z
J Inorg Biochem; 2015 Jan; 142():92-100. PubMed ID: 25450023
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
Fukuda M; Ohe Y; Kanzawa F; Oka M; Hara K; Saijo N
Anticancer Res; 1995; 15(2):393-8. PubMed ID: 7763011
[TBL] [Abstract][Full Text] [Related]
27. Platinum(ii) complexes showing high cytotoxicity toward A2780 ovarian carcinoma cells.
Choroba K; Machura B; Raposo LR; Małecki JG; Kula S; Pająk M; Erfurt K; Maroń AM; Fernandes AR
Dalton Trans; 2019 Sep; 48(34):13081-13093. PubMed ID: 31411239
[TBL] [Abstract][Full Text] [Related]
28. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
[TBL] [Abstract][Full Text] [Related]
29. N6-benzyladenosine derivatives as novel N-donor ligands of platinum(II) dichlorido complexes.
Starha P; Popa I; Trávníček Z; Vančo J
Molecules; 2013 Jun; 18(6):6990-7003. PubMed ID: 23771060
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes.
Gökçe M; Utku S; Gür S; Ozkul A; Gümüş F
Eur J Med Chem; 2005 Feb; 40(2):135-41. PubMed ID: 15694648
[TBL] [Abstract][Full Text] [Related]
31. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
Perez RP; O'Dwyer PJ; Handel LM; Ozols RF; Hamilton TC
Int J Cancer; 1991 May; 48(2):265-9. PubMed ID: 2019469
[TBL] [Abstract][Full Text] [Related]
32. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
[TBL] [Abstract][Full Text] [Related]
33. New steroidal 7-azaindole platinum(II) antitumor complexes.
Zamora A; Rodríguez V; Cutillas N; Yellol GS; Espinosa A; Samper KG; Capdevila M; Palacios O; Ruiz J
J Inorg Biochem; 2013 Nov; 128():48-56. PubMed ID: 23932925
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic activity of [Pt(pyr)(N-Etlm)Cl4].
Massacesi M; Matovic Z; Ponticelli G
Farmaco; 1993 Sep; 48(9):1327-30. PubMed ID: 8259989
[TBL] [Abstract][Full Text] [Related]
35. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
[TBL] [Abstract][Full Text] [Related]
36. The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines.
Rakić GM; Grgurić-Šipka S; Kaluđerović GN; Bette M; Filipović L; Aranđelović S; Radulović S; Tešić ZLj
Eur J Med Chem; 2012 Sep; 55():214-9. PubMed ID: 22858225
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation.
Cemazar M; Pipan Z; Grabner S; Bukovec N; Sersa G
Anticancer Res; 2006; 26(3A):1997-2002. PubMed ID: 16827135
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, in-vitro cytotoxic activity and DNA interactions of new dicarboxylatoplatinum(II) complexes with 2-hydroxymethylbenzimidazole as carrier ligands.
Utku S; Ozçelik AB; Gümüş F; Yılmaz S; Arsoy T; Açık L; Celebi Keskin A
J Pharm Pharmacol; 2014 Nov; 66(11):1593-605. PubMed ID: 25109360
[TBL] [Abstract][Full Text] [Related]
39. In vitro histoculture drug response assay and in vivo blood chemistry of a novel Pt(IV) compound, K104.
Kwon YE; Park JY; Kim WK
Anticancer Res; 2007; 27(1A):321-6. PubMed ID: 17352249
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antitumour activity of a new trinuclear platinum compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in human ovarian cancer cells.
Hamad SA; Beale P; Yu JQ; Huq F
Anticancer Res; 2014 Apr; 34(4):1923-9. PubMed ID: 24692727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]